Cargando…

Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, and the number of deaths due to cSCC is estimated to be greater than the number attributed to melanoma. While the majority of cSCC tumors are resectable with clear margins by standard excision practices, some les...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farberg, Aaron S., Fitzgerald, Alison L., Ibrahim, Sherrif F., Tolkachjov, Stan N., Soleymani, Teo, Douglas, Leah M., Kurley, Sarah J., Arron, Sarah T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850485/ https://www.ncbi.nlm.nih.gov/pubmed/34994967 http://dx.doi.org/10.1007/s13555-021-00673-y

Ejemplares similares

Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm
por: Singh, Gaurav, et al.
Publicado: (2023)

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
por: Borman, Sherri, et al.
Publicado: (2022)

A late presentation of inguinoscrotal cutaneous squamous cell carcinoma (cSCC) masquerading as hidradenitis suppurativa—a case report
por: Lahham, Elias Edward, et al.
Publicado: (2023)

Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
por: Bailly-Caillé, Barbara, et al.
Publicado: (2023)

IMP3 Expression as a Potential Tumour Marker in High-Risk Localisations of Cutaneous Squamous Cell Carcinoma: IMP3 in Metastatic cSCC
por: Klein, Maurice, et al.
Publicado: (2023)

Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review
por: Newman, Jason G., et al.
Publicado: (2021)

Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative Review
por: Farberg, Aaron S., et al.
Publicado: (2023)

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
por: Zauner, Roland, et al.
Publicado: (2023)

Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series
por: Au, Jeremiah H., et al.
Publicado: (2021)

Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression
por: Johnson, Ellise M., et al.
Publicado: (2022)

Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review
por: Brambullo, Tito, et al.
Publicado: (2021)

TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR
por: Zhang, Xu, et al.
Publicado: (2018)

Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC
por: Zhang, Guolong, et al.
Publicado: (2021)

Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022)

lncRNA EZR-AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway
por: Lu, Di, et al.
Publicado: (2021)

Cutaneous squamous cell carcinoma (SCC) arising in stump of amputated finger in a patient with resected glossal SCC
por: Uchida, Kenzo, et al.
Publicado: (2012)

miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB)
por: Zhou, Meijuan, et al.
Publicado: (2014)

Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells
por: Zhang, Qing-Ling, et al.
Publicado: (2019)

Radiotherapy in the Adjuvant and Advanced Setting of CSCC
por: Muto, Paolo, et al.
Publicado: (2021)

Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells
por: Zhang, Qing-Ling, et al.
Publicado: (2019)

Cost of illness del carcinoma cutaneo a cellule squamose (CSCC)
por: Marcellusi, Andrea, et al.
Publicado: (2020)

Caveat lector
por: Eldawlatly, Abdelazeem, et al.
Publicado: (2012)

Caveat emptor
por: Aswani, Yashant, et al.
Publicado: (2015)

Caveats for Dispensers
Publicado: (1921)

Caveat creator
por: Fuisz, Richard
Publicado: (2018)

Caveat scriptor
por: Loadsman, John A.
Publicado: (2018)

Caveats for Dispensers
Publicado: (1921)

Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma (SCC): IL-24 driven MMP-7
por: Mitsui, Hiroshi, et al.
Publicado: (2013)

Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma
por: Dubin, Danielle P., et al.
Publicado: (2019)

Squamous cell carcinoma (SCC) arising in esophageal colon interposition
por: Taslimi, Reza, et al.
Publicado: (2017)

Retraction: LncRNA SRA1 is downregulated in HPV-negative cervical squamous cell carcinoma (CSCC) and regulates cancer cell behaviors
Publicado: (2021)

Transcriptome Sequencing Demonstrates that Human Papillomavirus is not Active in Cutaneous Squamous Cell Carcinoma
por: Arron, Sarah Tuttleton, et al.
Publicado: (2011)

1998 International Technical Conference on Circuits/Systems, Computers and Communications - ITC-CSCC '98
Publicado: (1998)

The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
por: Inman, Gareth J., et al.
Publicado: (2018)

No evidence for integrated viral DNA in the genome sequence of cutaneous squamous cell carcinoma
por: Dimon, Michelle T., et al.
Publicado: (2014)

The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study
por: Farag, Azza Gaber Antar, et al.
Publicado: (2021)

Caveats of bisphosphonate abuse
por: Agarwala, Sanjay, et al.
Publicado: (2016)

Expression of Concern: LncRNA SRA1 is downregulated in HPV-negative cervical squamous cell carcinoma (CSCC) and regulates cancer cell behaviors
Publicado: (2020)

Management of HPV-Related Squamous Cell Carcinoma of the Head and Neck: Pitfalls and Caveat
por: Perri, Francesco, et al.
Publicado: (2020)

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
por: Green, J, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kje0npc7je45a9saf2f5rbdbv8